A new study of migraine sufferers suggests that what you're told when your doctor prescribes medication can influence your body's response to it. Researchers from Harvard Medical School and Beth Israel Deaconess Medical Center in Boston ...
Tags: Power of Suggestion, Migraine Drug
Photo: Tekla Perry One of Samsung's new curved TVs Press day, the day before the official opening of the International Consumer Electronics Show (CES), always brings new product and technology announcements from the large TV ...
Tags: CES, TV, Ultra High Definition, 4K resolution, Curving the Screen
Samsung has taken a dual-focused strategy towards TV at CES, showcasing "proof of concept", panels as well as a range of Ultra HD and Full HD panels that are set to hit the market in 2014. Following the brand's press conference yesterday ...
Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was ...
Tags: create nanoparticles, cancer-killing drugs, breast cancer, cancer cell
Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of critically ill patients, announced today that its investor group and employee shareholders ...
Tags: Ikaria, sell the Commercial Business, Madison Dearborn Partners
Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
Security vendor Symantec has discovered a Linux worm called Linux.Darlloz that has been engineered to exploit a known bug in PHP (php-cgi Information Disclosure Vulnerability) that was patched last year. Vulnerable devices include unpatched ...
Tags: Computer Products, software
DBV Technologies, creator of Viaskin, has entered into a collaboration agreement with BioNet-Asia and the University of Geneva (UNIGE) to work on a whooping cough (pertussis) booster vaccine. The clinical proof of concept product ...
Tags: DBV Technologies, Booster Vaccine
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma
Lloyds Bank has revealed how using service virtualisation has helped it cut app development costs by reducing testing times and highlighting defects earlier so that they can be fixed more cheaply. The bank, which uses CA ...
Tags: lloyds, bank, service, virtualisation, app, development, cost
Medtronic's Valiant 'Mona LSA' branch thoracic stent graft system demonstrated proof of concept in a first-in-human study being conducted under the US Food and Drug Administration (FDA)'s ‘Innovation Pathway’ early feasibility ...
Tags: stent graft system, Medicine
Mendix, the app platform company for the enterprise, has announced a partnership with Triumph Consultancy Services, a specialist life sciences consultancy that has been working for more than 12 years with biopharma, CRO, and medical device ...
Synta Pharmaceuticals has announced the publication of the company's first patent application covering its proprietary Hsp90-inhibitor drug conjugate (HDC) platform, which leverages the company's expertise in chaperone biology and medicinal ...